U.S. Markets close in 1 hr 34 mins

Diabetic Foot Ulcer Treatment Market Worth $11.16 Billion at 6.8% CAGR; Rise in Clinical Trials to Augment Market, says Fortune Business Insights™

Key Companies Covered in the Diabetic Foot Ulcer (DFU) Treatment Market Research Report are Integra LifeSciences Corporation., Smith & Nephew, Tissue Regenix, Coloplast Corp, B. Braun Melsungen AG, 3M, Cardinal Health., ConvaTec Group Plc, Mölnlycke Health Care AB. and other key market players.

Pune, Jan. 15, 2020 (GLOBE NEWSWIRE) -- The global Diabetic Foot Ulcer Treatment Market size is prophesized to reach USD 11.09 billion by 2026 owing to the increasing prevalence of diabetic foot ulcers among diabetic patients worldwide. A report published by Fortune Business Insights™ titled, “Diabetic Foot Ulcer (DFU) Treatment Market Size, Share & Industry Analysis, By Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, Neuro-ischemic Ulcer), By Product (Wound-care Dressings, Wound-care Devices, Active Therapies, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2019-2026,” states that market value was USD 6.62 billion in 2018. It is likely to exhibit a CAGR of 6.8% and grow steadily within the forecast duration, 2019- 2026.

Report Overview:

The Diabetic Foot Ulcer Treatment Market analysis offers a 360-degree overview of the market with a major emphasis on growth drivers, restraints, challenges, and opportunities. The report lists various segments of the market. It also provides a competitive landscape with base and forecast figures and the CAGR. The report also lists the names of significant players and their key strategies such as mergers and acquisitions, product launches, investments in research and development of clinical trials, company collaborations, and other Diabetic Foot Ulcer Treatment Market trends.


For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/diabetic-foot-ulcer-dfu-treatment-market-101948


Rising Geriatric Population and Increasing Cases of Diabetic Foot Ulcer to Boost Market

The increasing prevalence of diabetes is a major factor augmenting the Diabetic Foot Ulcer Treatment Market growth. In addition, the rise in the geriatric population and their vulnerability to various issues are also opening doors of opportunity for the market. As per the article published by the National Center for Biotechnology Information, diabetic foot ulcer is 13% prevalent in North America. It also states the yearly incidence of necrosis or diabetic foot ulcer is about 2-5%, and the lifetime risks vary between 15 to 20%. The above figures indicate a large number of the patient pool for availing treatment options for a diabetic foot ulcer. This, in turn, is anticipated to help increase the overall Diabetic Foot Ulcer Treatment Market size during the forecast period.

The increasing awareness about diabetic ulcers and the availability of treatment options for this ulcer is anticipated to further attract high Diabetic Foot Ulcer Treatment Market revenue in the coming years. Furthermore, ongoing clinical trials that yielded favorable results for treating diabetic foot ulcer is further prognosticated to increase the overall Diabetic Foot Ulcer Treatment Market growth in the near future.

High Product Cost to Help North America Earn Dominate Share

In terms of geographical outlook, North America earned the dominant Diabetic Foot Ulcer Treatment Market share in the year 2018. This is owing to the rising prevalence of foot ulcers among people with diabetes, and the high cost of products. Additionally, the advent of advanced technologies for therapeutic procedures and high expenditure on health is also responsible for the region to dominate the market.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/diabetic-foot-ulcer-dfu-treatment-market-101948


On the other side, Europe ranked second largest Diabetic Foot Ulcer Treatment Market share on account of the rise in adoption of advanced options for treatment in nations such as U.K., France, and Germany. Furthermore, the increasing geriatric population and rising prevalence of diabetic foot ulcers in Asia Pacific are likely to help this region witness a high CAGR in the forecast period.

Players to Focus on Geographical Expansion for Earning Lion’s Share in Market

Currently, the market is dominated by four significant players namely Mölnlycke Health Care AB., Coloplast Corp, ConvaTec Group Plc, and Smith & Nephew. This dominance is attributed to the strong presence of the brand and the presence of a wide range of product offerings. Besides this, there is continuous investment in product development and robust speed in research activities which will further help to attract high Diabetic Foot Ulcer Treatment Market revenue in the forecast period. In addition, Players are also stressing on entering into strategic partnerships for expanding their geographical boundaries worldwide.

Some of the key industry developments in the Diabetic Foot Ulcer Treatment Market are:

July 2018 – A German wound care products vendor SastoMed GmbH was acquired by Mölnlycke. The main objective is to expand their product offerings for accelerating their wound healing process and treating chronic wounds such as diabetic foot ulcers.

December 2017 – FDA approved Sanuwave Heath Inc. for marketing its first shock wave device called Dermapace System, meant for treating diabetic foot ulcers.

December 2019 Orpyx SI Sensory Insoles with remote patient monitoring was launched by Orpyx Medical Technologies Inc. This is mainly used for preventing neuropathy-related ulcers and diabetic foot ulcers.


List of the key Companies Operating in the
Diabetic Foot Ulcer Treatment Market are:

  • Integra LifeSciences Corporation.
  • Smith & Nephew
  • Tissue Regenix
  • Coloplast Corp
  • B. Braun Melsungen AG
  • 3M
  • Cardinal Health.
  • ConvaTec Group Plc
  • Mölnlycke Health Care AB.
  • Other Players


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/diabetic-foot-ulcer-dfu-treatment-market-101948


Detailed Table of Content:

1.      Introduction

1.1.  Research Scope

1.2.  Market Segmentation

1.3.  Research Methodology

1.4.  Definitions and Assumptions

2.      Executive Summary

3.      Market Dynamics

3.1.  Market Drivers

3.2.  Market Restraints

3.3.  Market Opportunities

4.      Key Insights

4.1.  Prevalence of Diabetic Foot Ulcer by Key Countries/Regions

4.2.  The Regulatory Scenario by Key Countries/Regions

4.3.  Overview of New Product Launches and Developments

4.4.  Key Industry Developments (Mergers, Acquisitions, and Partnerships)

5.      Global Diabetic Foot Ulcer (DFU) Treatment Market Analysis, Insights and Forecast, 2015-2026

5.1.  Key Findings / Summary

5.2.  Market Analysis, Insights and Forecast – By Ulcer Type

5.2.1.      Neuropathic Ulcer

5.2.2.      Ischemic Ulcer

5.2.3.      Neuro-Ischemic Ulcer

5.3.  Market Analysis, Insights and Forecast – By Product

5.3.1.      Wound-care Dressings

5.3.1.1.      Antimicrobial Dressing

5.3.1.2.      Foam Dressing

5.3.1.3.      Film Dressings

5.3.1.4.      Alginate Dressings

5.3.1.5.      Hydrogel Dressings

5.3.1.6.      Other Dressings

5.3.2.      Wound-care Devices -

5.3.2.1.      Negative Pressure Wound Therapy

5.3.2.2.      Ultrasound Therapy

5.3.2.3.      HBOT

5.3.2.4.      Others

5.3.3.      Active Therapies

5.3.3.1.      Skin Grafts & Substitutes,

5.3.3.2.      Growth Factors

5.3.3.3.      Others

5.3.4.      Others

5.4.  Market Analysis, Insights and Forecast – By End User

5.4.1.      Hospitals

5.4.2.      Clinics

5.4.3.      Ambulatory Surgical Centers

5.4.4.      Homecare Settings

5.5.  Market Analysis, Insights and Forecast – By Region

5.5.1.      North America

5.5.2.      Europe

5.5.3.      Asia Pacific

5.5.4.      Latin America

5.5.5.      Middle East & Africa

TOC Continued….!


Request for Customization:  https://www.fortunebusinessinsights.com/enquiry/customization/diabetic-foot-ulcer-dfu-treatment-market-101948


Have a Look at Related Reports:

Advanced Wound Care Market Size, Share and Industry Analysis, By Product (Advanced Wound Dressings, Wound Care Devices & Active Wound Care), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, Others), By End User, and Regional Forecast 2018-2025

Active Wound Care Market Size, Share and Industry Analysis by Product Type (Biological Skin Equivalents, Growth Factors, Biological Dressings, Others), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers), By End User (Hospitals, Clinics, Home Care Settings), and Regional Forecast 2018-2025

Wound Care Devices Market Size, Share and Industry Analysis By Product Type (Negative Pressure Wound Therapy (NPWT), Hyperbaric Oxygen Therapy (HBOT), Extracorporeal Shock Wave Therapy (ESWT)), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds), End Users (Hospitals, Clinics, Home Care Settings) and Regional Forecast, 2018 – 2025

Chronic Wound Care Market Size, Share and Global Trend By Type of Chronic Wound (Venous Ulcer, Arterial Ulcer, Diabetic Ulcer, Pressure Sore), By Product (Wound Dressings, Wound Treatment Devices, Cleansing Agents, Antibiotics), By End User (Hospitals and Wound Care Centres, Ambulatory Surgery Centres, Homecare Settings), Geography Forecast till 2026

Blood Glucose Meters Market Size, Share and Global Trend by Product (Continuous Glucose Monitoring Devices, Self-Monitoring Blood Glucose (SMBG) Systems), By Technique (Invasive, Non-Invasive), By Type (Wearable, Non-Wearable), By Distribution Channel (Institutional Sales, Retail Sales) and Geography forecast 2026

Diabetes Drugs Market Size, Share and Global Trend By Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors), Diabetes Type (Type 1, Type 2), Route of Administration (Oral, Subcutaneous, Intravenous), Distribution Channel (Online pharmacies, Hospital Pharmacies, Retail Pharmacies) & Geography Forecast till 2026

Diabetes Devices Market Size, Share and Global Trend By Product (Monitoring Devices, Treatment Devices), By Distribution Channel (Institutional Sales, Retail Sales) and Geography Forecast till 2026

Blood Glucose Monitoring Systems Market Size, Share & Industry Analysis, By Device (Continuous Blood Glucose Monitoring Systems, Self-monitoring of Blood Glucose Systems), By Type (Invasive, Non-invasive), By Modality (Wearable, Non-wearable), By Distribution Channel (Institutional Sales, Retail Sales), and Regional Forecast 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/diabetic-foot-ulcer-dfu-treatment-market-9508